DOXOrubicin Hydrochloride Liposome Injection 50mg/ recalled over foreign material
- Recall date
- May 13, 2026
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Sun Pharmaceutical Industries, Inc. recalls Aisling — DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL
- Brand / firm
- Sun Pharmaceutical Industries, Inc., Aisling
Why it was recalled
Presence of glass particles — Potential Foreign Material
What was recalled
DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL
Read the official recall notice →
Get recall alerts
Free email alert whenever Sun Pharmaceutical Industries, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sun Pharmaceutical Industries, Inc., Aisling